公开(公告)号：US10787438B2

公开(公告)日：2020-09-29

申请号：US16744283

申请日：2020-01-16

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D403/14 ,  A61K31/403 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US20200148669A1

公开(公告)日：2020-05-14

申请号：US16744283

申请日：2020-01-16

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D403/14 ,  C07D403/04 ,  C07D401/14 ,  C07D401/04 ,  A61K31/403

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US20170183328A1

公开(公告)日：2017-06-29

申请号：US15381295

申请日：2016-12-16

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D403/14 ,  C07D403/04 ,  C07D401/04 ,  C07D401/14

CPC classification number: C07D403/14 ,  A61K31/403 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US20170165284A1

公开(公告)日：2017-06-15

申请号：US15434508

申请日：2017-02-16

Applicant: Pfizer Inc.

Inventor： Spiros Liras ,  Vincent Mascitti ,  Benjamin Thuma

IPC: A61K31/706 ,  A61K31/7056 ,  A61K31/7008

CPC classification number: A61K31/706 ,  A61K31/7008 ,  A61K31/7056 ,  A61K38/465 ,  A61K47/64 ,  C07D309/14 ,  C07D493/08 ,  C07H13/04 ,  C07H15/08 ,  C07H15/12 ,  C07H15/26 ,  C07K5/06078 ,  C12Y301/00 ,  Y02A50/463

Abstract: Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.

公开(公告)号：US20160207953A1

公开(公告)日：2016-07-21

申请号：US15093178

申请日：2016-04-07

Applicant: Pfizer Inc.

Inventor： Spiros Liras ,  Vincent Mascitti ,  Benjamin Thuma

IPC: C07H15/08 ,  A61K31/7008 ,  C07H15/26 ,  A61K38/46 ,  C07H15/12 ,  A61K31/706 ,  C07K5/065 ,  C07H13/04 ,  A61K31/7056

CPC classification number: A61K31/706 ,  A61K31/7008 ,  A61K31/7056 ,  A61K38/465 ,  A61K47/64 ,  C07D309/14 ,  C07D493/08 ,  C07H13/04 ,  C07H15/08 ,  C07H15/12 ,  C07H15/26 ,  C07K5/06078 ,  C12Y301/00 ,  Y02A50/463

Abstract: Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.

公开(公告)号：US10988463B2

公开(公告)日：2021-04-27

申请号：US16999295

申请日：2020-08-21

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D401/14 ,  C07D403/14 ,  A61K31/403 ,  C07D401/04 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US10174007B2

公开(公告)日：2019-01-08

申请号：US15729885

申请日：2017-10-11

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: A61K31/403 ,  C07D403/14 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US10039778B2

公开(公告)日：2018-08-07

申请号：US15434508

申请日：2017-02-16

Applicant: Pfizer Inc.

Inventor： Spiros Liras ,  Vincent Mascitti ,  Benjamin Thuma

IPC: C07D493/08 ,  A61K31/35 ,  A61K31/706 ,  C07D309/14 ,  C07H13/04 ,  C07H15/26 ,  A61K31/7008 ,  A61K31/7056 ,  A61K38/46 ,  C07H15/08 ,  C07H15/12 ,  C07K5/065 ,  A61K47/64

Abstract: Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.

公开(公告)号：US20180037575A1

公开(公告)日：2018-02-08

申请号：US15729885

申请日：2017-10-11

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D403/14 ,  C07D401/14 ,  C07D401/04 ,  C07D403/04 ,  A61K31/403

CPC classification number: C07D403/14 ,  A61K31/403 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.

公开(公告)号：US09809579B2

公开(公告)日：2017-11-07

申请号：US15381295

申请日：2016-12-16

Applicant: Pfizer Inc.

Inventor： Matthew Dowling ,  Dilinie Fernando ,  Kentaro Futatsugi ,  Kim Huard ,  Thomas Victor Magee ,  Brian Raymer ,  Andre Shavnya ,  Aaron Smith ,  Benjamin Thuma ,  Andy Tsai ,  Meihua Tu

IPC: C07D401/14 ,  C07D403/14 ,  C07D403/04 ,  C07D401/04 ,  A61K31/403

CPC classification number: C07D403/14 ,  A61K31/403 ,  C07D401/04 ,  C07D401/14 ,  C07D403/04

Abstract: Provided herein are substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors, processes to make said compounds, and methods comprising administering said compounds to a mammal in need thereof.